ACEP-话题@MedSci

#ACEP#

38篇内容 | 1252人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1779320, encodeId=6a8f1e7932046, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Blood：阿巴西普（abatacept），一种新型免疫调节剂，可明显改善类固醇耐药性慢性移植物抗宿主病患者预后, objectType=article, longId=132734, objectId=dd42132e3410, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd42132e3410, replyNumber=0, likeNumber=75, createdTime=2018-09-21, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd42132e3410, moduleTitle=Blood：阿巴西普（abatacept），一种新型免疫调节剂，可明显改善类固醇耐药性慢性移植物抗宿主病患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd42132e3410)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779319, encodeId=e3b11e79319cb, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=2017 ACEP临床决策：需要进行再灌注治疗的急性ST段抬高型心肌梗死患者的急诊管理, objectType=article, longId=122143, objectId=a550122143af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a550122143af, replyNumber=0, likeNumber=70, createdTime=2018-03-30, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a550122143af, moduleTitle=2017 ACEP临床决策：需要进行再灌注治疗的急性ST段抬高型心肌梗死患者的急诊管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a550122143af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778944, encodeId=4c4d1e7894413, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Blood：阿巴西普（abatacept），一种新型免疫调节剂，可明显改善类固醇耐药性慢性移植物抗宿主病患者预后, objectType=article, longId=132734, objectId=dd42132e3410, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd42132e3410, replyNumber=0, likeNumber=74, createdTime=2018-07-13, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd42132e3410, moduleTitle=Blood：阿巴西普（abatacept），一种新型免疫调节剂，可明显改善类固醇耐药性慢性移植物抗宿主病患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd42132e3410)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779318, encodeId=9bcf1e7931884, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=2017 ACEP临床决策：成年精神病患者急诊室诊断和管理要点, objectType=article, longId=105735, objectId=f905105e3524, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f905105e3524, replyNumber=0, likeNumber=82, createdTime=2018-04-08, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f905105e3524, moduleTitle=2017 ACEP临床决策：成年精神病患者急诊室诊断和管理要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f905105e3524)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778943, encodeId=a6361e789439c, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=2017 ACEP临床决策：需要进行再灌注治疗的急性ST段抬高型心肌梗死患者的急诊管理, objectType=article, longId=122143, objectId=a550122143af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a550122143af, replyNumber=0, likeNumber=65, createdTime=2018-02-18, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a550122143af, moduleTitle=2017 ACEP临床决策：需要进行再灌注治疗的急性ST段抬高型心肌梗死患者的急诊管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a550122143af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779317, encodeId=14e91e7931707, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=2017 ACEP临床决策：急性一氧化碳中毒患者急诊科评估和管理要点, objectType=article, longId=105662, objectId=dfe8105662e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfe8105662e3, replyNumber=0, likeNumber=76, createdTime=2018-04-16, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfe8105662e3, moduleTitle=2017 ACEP临床决策：急性一氧化碳中毒患者急诊科评估和管理要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfe8105662e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778941, encodeId=8eee1e7894153, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=2017 ACEP临床决策：急性一氧化碳中毒患者急诊科评估和管理要点, objectType=article, longId=105662, objectId=dfe8105662e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfe8105662e3, replyNumber=0, likeNumber=70, createdTime=2017-07-23, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfe8105662e3, moduleTitle=2017 ACEP临床决策：急性一氧化碳中毒患者急诊科评估和管理要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfe8105662e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778942, encodeId=19a61e7894277, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=2017 ACEP临床决策：成年精神病患者急诊室诊断和管理要点, objectType=article, longId=105735, objectId=f905105e3524, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f905105e3524, replyNumber=0, likeNumber=49, createdTime=2018-03-03, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f905105e3524, moduleTitle=2017 ACEP临床决策：成年精神病患者急诊室诊断和管理要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f905105e3524)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778940, encodeId=1d501e78940f7, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=NEJM：Belatacept对于肾移植患者的长期（7年）效果较好, objectType=article, longId=62703, objectId=376562e038c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=376562e038c, replyNumber=0, likeNumber=70, createdTime=2016-09-08, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=376562e038c, moduleTitle=NEJM：Belatacept对于肾移植患者的长期（7年）效果较好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=376562e038c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779316, encodeId=5ddc1e7931630, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=NEJM：Belatacept对于肾移植患者的长期（7年）效果较好, objectType=article, longId=62703, objectId=376562e038c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=376562e038c, replyNumber=0, likeNumber=53, createdTime=2016-10-31, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=376562e038c, moduleTitle=NEJM：Belatacept对于肾移植患者的长期（7年）效果较好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=376562e038c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778939, encodeId=62061e78939e2, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Contraception：避孕器LNG20的有效性和安全性, objectType=article, longId=50788, objectId=f1fc50e88a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1fc50e88a2, replyNumber=0, likeNumber=91, createdTime=2015-09-14, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1fc50e88a2, moduleTitle=Contraception：避孕器LNG20的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1fc50e88a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779315, encodeId=fe281e79315ac, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Contraception：避孕器LNG20的有效性和安全性, objectType=article, longId=50788, objectId=f1fc50e88a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1fc50e88a2, replyNumber=0, likeNumber=48, createdTime=2015-12-05, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1fc50e88a2, moduleTitle=Contraception：避孕器LNG20的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1fc50e88a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778937, encodeId=98291e78937bb, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Targacept公司在中期阶段失败后终止阿尔茨海默氏症药物试验, objectType=article, longId=37870, objectId=56f63e8706d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56f63e8706d, replyNumber=0, likeNumber=61, createdTime=2014-10-26, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56f63e8706d, moduleTitle=Targacept公司在中期阶段失败后终止阿尔茨海默氏症药物试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56f63e8706d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779314, encodeId=da8e1e793148a, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=8个临床试验全部失败，Targacept误入临床研究雷区, objectType=article, longId=38524, objectId=96c73852448, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96c73852448, replyNumber=0, likeNumber=62, createdTime=2015-04-03, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96c73852448, moduleTitle=8个临床试验全部失败，Targacept误入临床研究雷区, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96c73852448)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779313, encodeId=a0901e7931349, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Targacept公司在中期阶段失败后终止阿尔茨海默氏症药物试验, objectType=article, longId=37870, objectId=56f63e8706d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56f63e8706d, replyNumber=0, likeNumber=83, createdTime=2015-06-19, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56f63e8706d, moduleTitle=Targacept公司在中期阶段失败后终止阿尔茨海默氏症药物试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56f63e8706d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778938, encodeId=dc8b1e7893805, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=8个临床试验全部失败，Targacept误入临床研究雷区, objectType=article, longId=38524, objectId=96c73852448, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96c73852448, replyNumber=0, likeNumber=78, createdTime=2015-07-17, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96c73852448, moduleTitle=8个临床试验全部失败，Targacept误入临床研究雷区, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96c73852448)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1779312, encodeId=afc01e793129c, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Contraception：激素类避孕药降低维生素B12 意义不大, objectType=article, longId=5737, objectId=139f5e3777, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=139f5e3777, replyNumber=0, likeNumber=91, createdTime=2012-09-12, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=139f5e3777, moduleTitle=Contraception：激素类避孕药降低维生素B12 意义不大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=139f5e3777)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778936, encodeId=873e1e7893696, content=<a href='/topic/show?id=c33118392a' target=_blank style='color:#2F92EE;'>#ACEP#</a>, objectTitle=Contraception：激素类避孕药降低维生素B12 意义不大, objectType=article, longId=5737, objectId=139f5e3777, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=139f5e3777, replyNumber=0, likeNumber=63, createdTime=2012-06-23, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=139f5e3777, moduleTitle=Contraception：激素类避孕药降低维生素B12 意义不大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=139f5e3777)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACEP

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

Blood：阿巴西普（abatacept），一种新型免疫调节剂，可明显改善类固醇耐药性慢性移植物抗宿主病患者预后

2018-09-21

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

2017 ACEP临床决策：需要进行再灌注治疗的急性ST段抬高型心肌梗死患者的急诊管理

2018-03-30

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

Blood：阿巴西普（abatacept），一种新型免疫调节剂，可明显改善类固醇耐药性慢性移植物抗宿主病患者预后

2018-07-13

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

2017 ACEP临床决策：成年精神病患者急诊室诊断和管理要点

2018-04-08

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

2017 ACEP临床决策：需要进行再灌注治疗的急性ST段抬高型心肌梗死患者的急诊管理

2018-02-18

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

2017 ACEP临床决策：急性一氧化碳中毒患者急诊科评估和管理要点

2018-04-16

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

2017 ACEP临床决策：急性一氧化碳中毒患者急诊科评估和管理要点

2017-07-23

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

2017 ACEP临床决策：成年精神病患者急诊室诊断和管理要点

2018-03-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

NEJM：Belatacept对于肾移植患者的长期（7年）效果较好

2016-09-08

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

NEJM：Belatacept对于肾移植患者的长期（7年）效果较好

2016-10-31

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

Contraception：避孕器LNG20的有效性和安全性

2015-09-14

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

Contraception：避孕器LNG20的有效性和安全性

2015-12-05

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

Targacept公司在中期阶段失败后终止阿尔茨海默氏症药物试验

2014-10-26

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

8个临床试验全部失败，Targacept误入临床研究雷区

2015-04-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

Targacept公司在中期阶段失败后终止阿尔茨海默氏症药物试验

2015-06-19

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

8个临床试验全部失败，Targacept误入临床研究雷区

2015-07-17

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

Contraception：激素类避孕药降低维生素B12 意义不大

2012-09-12

xiaoyeshuang (审核中...)

前往app查看评论内容

#ACEP#

Contraception：激素类避孕药降低维生素B12 意义不大

2012-06-23

科室
- - 订阅+
  - 更多科室
工具
服务